| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Voyager Therapeutics, Inc. (VYGR) has 6 insiders with recent SEC Form 4 filings, including 1 buy and 8 sells. VYGR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 484.1K | $1.69M | - | |
| COO | 199.7K | $699.1K | - | |
| Other | 183.9K | $643.7K | - | |
| CFO | 151.4K | $530.0K | - | |
| Other | 145.7K | $510.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2018 | Ravina Bernard | Chief Medical Officer | Sell | 2,451 | $18.24 | $44,706.24 | -33.3% | |
| Jan 10, 2018 | Ravina Bernard | Chief Medical Officer | Sell | 3,630 | $16.40 | $59,532.00 | -33.1% | |
| Dec 11, 2017 | Ravina Bernard | Chief Medical Officer | Sell | 5,490 | $13.63 | $74,828.70 | -33.3% | |
| Nov 10, 2017 | Ravina Bernard | Chief Medical Officer | Sell | 5,490 | $13.26 | $72,797.40 | -25.0% | |
| Oct 10, 2017 | Ravina Bernard | Chief Medical Officer | Sell | 10,980 | $20.33 | $223,223.40 | -33.3% | |
| Sep 11, 2017 | Ravina Bernard | Chief Medical Officer | Sell | 16,470 | $12.87 | $211,914.00 | -16.7% | |
| Sep 5, 2017 | Ravina Bernard | Chief Medical Officer | Sell | 5,490 | $10.00 | $54,900.00 | -24.2% | |
| Jan 14, 2016 | Paul Steven M | President And CEO | Buy | 10,000 | $14.07 | $140,690.00 | +1.2% |